These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8871645)

  • 1. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13.
    Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR
    J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.
    Martin R; Utz U; Coligan JE; Richert JR; Flerlage M; Robinson E; Stone R; Biddison WE; McFarlin DE; McFarland HF
    J Immunol; 1992 Mar; 148(5):1359-66. PubMed ID: 1371525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.
    Saruhan-Direskeneli G; Weber F; Meinl E; Pette M; Giegerich G; Hinkkanen A; Epplen JT; Hohlfeld R; Wekerle H
    Eur J Immunol; 1993 Feb; 23(2):530-6. PubMed ID: 7679649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
    Hong J; Zang YC; Tejada-Simon MV; Kozovska M; Li S; Singh RA; Yang D; Rivera VM; Killian JK; Zhang JZ
    J Immunol; 1999 Sep; 163(6):3530-8. PubMed ID: 10477628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Zhang J; Witek C; Matsui M; Modabber Y; Ota K; Hafler DA
    J Immunol; 1994 Jun; 152(11):5581-92. PubMed ID: 7514641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif.
    Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK
    Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes.
    Giegerich G; Pette M; Meinl E; Epplen JT; Wekerle H; Hinkkanen A
    Eur J Immunol; 1992 Mar; 22(3):753-8. PubMed ID: 1372258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
    Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
    J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.
    Chou YK; Morrison WJ; Weinberg AD; Dedrick R; Whitham R; Bourdette DN; Hashim G; Offner H; Vandenbark AA
    J Immunol; 1994 Mar; 152(5):2520-9. PubMed ID: 7510747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN; Chou YK; Whitham RH; Buckner J; Kwon HJ; Nepom GT; Buenafe A; Cooper SA; Allegretta M; Hashim GA; Offner H; Vandenbark AA
    J Immunol; 1998 Jul; 161(2):1034-44. PubMed ID: 9670985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
    J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.
    Grogan JL; Kramer A; Nogai A; Dong L; Ohde M; Schneider-Mergener J; Kamradt T
    J Immunol; 1999 Oct; 163(7):3764-70. PubMed ID: 10490973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.
    Huh J; Yao K; Quigley L; Ludwin SK; McFarland HF; Muraro PA; Martin R; Ito K
    J Neuroimmunol; 2004 Jun; 151(1-2):94-102. PubMed ID: 15145608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
    Kuwana M; Medsger TA; Wright TM
    J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
    Jaraquemada D; Martin R; Rosen-Bronson S; Flerlage M; McFarland HF; Long EO
    J Immunol; 1990 Nov; 145(9):2880-5. PubMed ID: 1698864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.